Immunological characteristics of diabetes in schizophrenia

[1]  P. Doraiswamy,et al.  A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. , 2004, The Journal of clinical psychiatry.

[2]  D. Cohen.  Atypical Antipsychotics and New Onset Diabetes mellitus , 2004, Pharmacopsychiatry.

[3]  S. Chong,et al.  Diabetes Mellitus and Impaired Glucose Tolerance in Patients with Schizophrenia , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[4]  J. Lieberman,et al.  Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. , 2003, The American journal of psychiatry.

[5]  P. Doraiswamy,et al.  Olanzapine‐Associated Diabetes Mellitus , 2002, Pharmacotherapy.

[6]  E. Koller,et al.  Clozapine-associated diabetes. , 2001, The American journal of medicine.

[7]  D. Grobbee,et al.  Low prevalence of GAD and IA2 antibodies in schoolchildren from a village in the southwestern section of the Netherlands. , 2001, Human immunology.

[8]  Baan Ca,et al.  [Disease burden of diabetes mellitus type II in the Netherlands: incidence, prevalence and mortality ]. , 2001 .

[9]  D. Grobbee,et al.  Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and threshold values. , 1999, Clinical chemistry.

[10]  L. Bouter,et al.  Low Prevalence of Antibodies to GAD65 in a 50- to 74-Year-Old General Dutch Population: The Hoorn Study , 1997, Diabetes Care.

[11]  A. Ziegler,et al.  Fifth International Serum Exchange Workshop for Insulin Autoantibody (IAA) Standardization , 1992, Diabetologia.

[12]  G. Finney.  JUVENILE ONSET DIABETES AND SCHIZOPHRENIA? , 1989, The Lancet.

[13]  L. Kuller,et al.  Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. , 2000, Diabetes.